Publications by authors named "Lynn Bonham"

Claim this Profile
T
Toll-Like Receptor 4 Agonist Injection With Concurrent Radiotherapy in Patients With Metastatic Soft Tissue Sarcoma: A Phase 1 Nonrandomized Controlled Trial.
Yongwoo David Seo, Hailing Lu, Graeme Black, Kimberly Smythe, Yuexin Yu, Lynn Bonham

JAMA Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravital imaging reveals distinct responses of depleting dynamic tumor-associated macrophage and dendritic cell subpopulations.
Marja Lohela, Amy-Jo Casbon, Aleksandra Olow, Lynn Bonham, Daniel Branstetter

Proc Natl Acad Sci U S A· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An antibody against the colony-stimulating factor 1 receptor depletes the resident subset of monocytes and tissue- and tumor-associated macrophages but does not inhibit inflammation.
Kelli P A MacDonald, James S Palmer, Stephen Cronau, Elke Seppanen, Stuart Olver, Lynn Bonham

Blood· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antileukemic activity of lysophosphatidic acid acyltransferase-beta inhibitor CT32228 in chronic myelogenous leukemia sensitive and resistant to imatinib.
Paul La Rosée, Taiping Jia, Shadmer Demehri, Nicolai Härtel, Peter de Vries, Lynn Bonham

Clin Cancer Res· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lysophosphatidic acid acyltransferase-beta (LPAAT-beta) is highly expressed in advanced ovarian cancer and is associated with aggressive histology and poor survival.
Catherine S M Diefenbach, Robert A Soslow, Alexia Iasonos, Irina Linkov, Cyrus Hedvat, Lynn Bonham

Cancer· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of lysophosphatidic acid acyltransferase-beta inhibition in acute leukemia.
Michael G Douvas, Karen N Hogan, YanShan Ji, David Hollenback, Lynn Bonham

Leuk Res· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Substrate specificity of lysophosphatidic acid acyltransferase beta -- evidence from membrane and whole cell assays.
David Hollenback, Lynn Bonham, Laura Law, Eddie Rossnagle, Lisa Romero

J Lipid Res· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lysophosphatidic acid acyltransferase-beta is a prognostic marker and therapeutic target in gynecologic malignancies.
Gregory M Springett, Lynn Bonham, Amanda Hummer, Irina Linkov, Dipika Misra

Cancer Res· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of apoptosis using inhibitors of lysophosphatidic acid acyltransferase-beta and anti-CD20 monoclonal antibodies for treatment of human non-Hodgkin's lymphomas.
John M Pagel, Christian Laugen, Lynn Bonham, Robert C Hackman, David M Hockenbery

Clin Cancer Res· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular characterization of PS-341 (bortezomib) resistance: implications for overcoming resistance using lysophosphatidic acid acyltransferase (LPAAT)-beta inhibitors.
Teru Hideshima, Dharminder Chauhan, Kenji Ishitsuka, Hiroshi Yasui, Noopur Raje, Lynn Bonham

Oncogene· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and SAR of 2-arylbenzoxazoles, benzothiazoles and benzimidazoles as inhibitors of lysophosphatidic acid acyltransferase-beta.
Baoqing Gong, Feng Hong, Cory Kohm, Lynn Bonham, Peter Klein

Bioorg Med Chem Lett· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor activity of lysophosphatidic acid acyltransferase-beta inhibitors, a novel class of agents, in multiple myeloma.
Teru Hideshima, Dharminder Chauhan, Toshiaki Hayashi, Klaus Podar, Masaharu Akiyama, Lynn Bonham

Cancer Res· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lysophosphatidic acid acyltransferase-beta: a novel target for induction of tumour cell apoptosis.
Lynn Bonham, David W Leung, Thayer White, David Hollenback, Peter Klein

Expert Opin Ther Targets· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of lysophosphatidic acid acyltransferase beta disrupts proliferative and survival signals in normal cells and induces apoptosis of tumor cells.
Michael Coon, Alexey Ball, Jeannine Pound, Sophe Ap, David Hollenback, Lynn Bonham

Mol Cancer Ther· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis